Physician profile
Laura Mackey
NPI 1457999617
$2,688.75
in general payments reported to CMS, 2019-2025
14 companies · $568 in 2025
The $568 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $637 · 2022: $309 · 2023: $766 · 2024: $409 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,742.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $607.23 | 2022-2024 | Xarelto |
| Terumo Medical Corporation | $378.09 | 2021-2025 | Angio-Seal, Metacross Otw |
| Novartis Pharmaceuticals Corporation | $246.45 | 2023-2025 | |
| Cardiovascular Systems INC. | $243.74 | 2021-2022 | |
| Amgen INC. | $198.44 | 2021-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.01 | 2022-2025 | Jardiance |
| Shockwave Medical, INC | $161.26 | 2021 | |
| Alnylam Pharmaceuticals INC. | $157.30 | 2023-2025 | Onpattro, Amvuttra |
| Janssen Scientific Affairs, LLC | $130.87 | 2021 | |
| Boston Scientific Corporation | $122.64 | 2025 | General - Balloon Catheters |
| Kiniksa Pharmaceuticals International, Plc | $117.36 | 2024 | Arcalyst |
| Philips North America LLC | $80.04 | 2022-2025 | Mcot |
| Scpharmaceuticals INC. | $53.94 | 2025 | |
| Irhythm Technologies, INC. | $28.38 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.